ANTX

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 6

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 5

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 4

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 3

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,362

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 2

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,999 shares

Expires 2031-04-29

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120223 · ownership.xml · derivative · entry 1

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,999

Underlying: Common Stock · 24,999 shares

Expires 2031-04-29

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 6

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 5

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 4

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 3

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,362

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 2

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,463 shares

Expires 2032-05-04

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120221 · ownership.xml · derivative · entry 1

FitzPatrick Margaret M · CIK 0001873879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,463

Underlying: Common Stock · 11,463 shares

Expires 2032-05-04

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 6

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 5

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 4

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 3

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,362

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 2

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,999 shares

Expires 2031-04-29

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120216 · ownership.xml · derivative · entry 1

Wong Stephanie · CIK 0001555744 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,999

Underlying: Common Stock · 24,999 shares

Expires 2031-04-29

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 6

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 5

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 4

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 3

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,362

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 2

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 99,999 shares

Expires 2031-04-29

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120214 · ownership.xml · derivative · entry 1

Zakrzewski Joseph S · CIK 0001331852 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,999

Underlying: Common Stock · 99,999 shares

Expires 2031-04-29

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 6

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 5

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 4

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 3

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,362

Underlying: Common Stock · 10,362 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 2

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,941 shares

Expires 2032-02-17

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120207 · ownership.xml · derivative · entry 1

Spigelman Melvin K · CIK 0001339901 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,941

Underlying: Common Stock · 16,941 shares

Expires 2032-02-17

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120200 · ownership.xml · derivative · entry 4

Readnour Robin Shane · CIK 0001914883 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120200 · ownership.xml · derivative · entry 3

Readnour Robin Shane · CIK 0001914883 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,742

Underlying: Common Stock · 23,742 shares

Expires 2033-06-06

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120200 · ownership.xml · derivative · entry 2

Readnour Robin Shane · CIK 0001914883 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,724 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120200 · ownership.xml · derivative · entry 1

Readnour Robin Shane · CIK 0001914883 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,724

Underlying: Common Stock · 20,724 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 6

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 267,650 shares

Expires 2033-02-22

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary measured from January 1, 2023, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 5

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,650

Underlying: Common Stock · 267,650 shares

Expires 2033-02-22

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary measured from January 1, 2023, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 4

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 225,000 shares

Expires 2032-05-11

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary measured from March 25, 2022, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 3

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2032-05-11

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary measured from March 25, 2022, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 2

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 249,999 shares

Expires 2031-04-29

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-120192 · ownership.xml · derivative · entry 1

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,999

Underlying: Common Stock · 249,999 shares

Expires 2031-04-29

F1 · derivative.exercise_price: The exercise price of the option is $3.91 per share, representing the closing price of the Issuer's common stock on the date of the repricing; provided that the exercise price will be increased to the original exercise price before repricing if, prior to the "Premium End Date" (as defined below), the repriced option is exercised or the Reporting Person's services with the Company is terminated. The "Premium End Date" means the earliest of: (i) September 19, 2027, (ii) the date of a change in control or (iii) the Reporting Person's death or disability.

F3 · price: On March 19, 2026, the board of directors of the Issuer approved the repricing of the option. Except as further described in footnote 1, all other terms of the option remain unchanged.

F2 · derivative.exercise_date: The option is fully vested.

SEC source: 0001193125-26-094490 · ownership.xml · nonDerivative · entry 1

Williams Sarah Joanne · CIK 0002108922 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,848

F1 · shares: Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on February 28, 2026.

F2 · balance_after: Includes (a) 48,375 RSUs which vest as follows: 1/4th of the shares vests in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2026, and the balance of (b) 10,938 RSUs which vest as follows: 1/4th of the RSUs vests in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2025, and (c) 11,850 RSUs which vest as follows: 1/16th of the RSUs vests in substantially equal installments quarterly (rounded down to the nearest whole number of shares) over four years from May 28, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date. A total of 3,501 shares from the aggregate number of the RSUs issued under (b) and (c) above were sold to cover taxes and a total of 814 shares were sold on the open market.

SEC source: 0001193125-26-064176 · ownership.xml · derivative · entry 2

Eizen Joshua M · CIK 0001949621 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-02-19

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-064176 · ownership.xml · nonDerivative · entry 1

Eizen Joshua M · CIK 0001949621 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,499

F1 · shares: Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · balance_after: Includes a balance of (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 60,000 RSUs which vest as follows: 25% of the RSUs vest on January 1, 2025, 50% of the RSUs vest on January 1, 2026, and 25% of the RSUs vest on July 1, 2026, (c) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, and (d) 58,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · balance_after: Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2025.

SEC source: 0001193125-26-064174 · ownership.xml · derivative · entry 2

Day Lucy · CIK 0001914510 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Stock · 77,000 shares

Expires 2036-02-19

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-064174 · ownership.xml · nonDerivative · entry 1

Day Lucy · CIK 0001914510 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,363

F1 · shares: Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · balance_after: Includes a balance of (a) 27,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) 46,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · balance_after: Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2025.

SEC source: 0001193125-26-064166 · ownership.xml · nonDerivative · entry 1

Williams Sarah Joanne · CIK 0002108922 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,175

F1 · shares: Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · balance_after: Includes the balance of (a) 10,938 RSUs which vest as follows: 1/4th of the RSUs vest in substantially equal installments annually (rounded down to the nearest whole number of shares) over four years from January 1, 2025, and (b) 11,850 RSUs which vest as follows: 1/16th of the RSUs vest in substantially equal installments quarterly (rounded down to the nearest whole number of shares) over four years from May 28, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date. A total of 3,174 shares from the aggregate number of the RSUs issued under (a) and (b) above were sold to cover taxes and a total of 814 shares were sold on the open market.

SEC source: 0001193125-26-064141 · ownership.xml · derivative · entry 2

Chanda Sanjay · CIK 0001571820 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Stock · 77,000 shares

Expires 2036-02-19

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-064141 · ownership.xml · nonDerivative · entry 1

Chanda Sanjay · CIK 0001571820 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,823

F1 · shares: Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · balance_after: Includes a balance of (a) 27,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024 and (b) 50,250 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2025, in each case subject to the Reporting Person's continuous service through each applicable vesting date.

F3 · balance_after: Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2025.

SEC source: 0001193125-26-064151 · ownership.xml · derivative · entry 5

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,500

Underlying: Common Stock · 224,500 shares

Expires 2036-02-19

F6 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

SEC source: 0001193125-26-064151 · ownership.xml · nonDerivative · entry 1

Easom Eric · CIK 0001914503 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,630

F1 · shares: Represents restricted stock units ("RSUs") which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · balance_after: Includes a balance of (i) 145,250 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2025 and (ii) 99,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, in each case subject to the Reporting Person's continuous service through each applicable vesting date.